The guidance encourages the use of Bayesian statistics in drug trials. Instead of starting from scratch and only adding new ...
The FDA has opened the door to the use of Bayesian statistical methods in clinical trials. The worry: Introducing ...
Explore the debate surrounding animal testing as new methods may jeopardise patient safety if not properly validated.
Although new approach methodologies (NAMs) are not that new, they remain a crucial and evolving aspect of the development and production of biopharmaceuticals. “NAMs have been around for 20 years plus ...
As regulatory authorities accelerate the use of New Approach Methodologies (NAMs), the drug discovery landscape is changing dramatically. This webinar explores how NAMs, immunology-driven platforms, ...
Cancer remains one of the most pressing health challenges of our time, yet drug development in oncology faces persistent hurdles. Despite billions invested, nearly 90% of drugs that succeed in animal ...
NIEHS' collaboration with Simulations Plus is part of a national effort to modernize chemical safety assessment through AI-powered new approach methodologies and will continue the application of the ...
As excitement around animal testing alternatives reaches a fever pitch, Charles River Laboratories is making a move to strengthen its development of new approach methodologies (NAMs) that can ...
New approach methodologies (NAMs) – such as organoids, spheroids and microfluidic chip systems – aim to streamline early-stage drug discovery and revolutionize preclinical testing by augmenting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results